Merck

Health news

UK approves use of anti-COVID pill molnupiravir

Molnupiravir will be offered to at-risk patients who already have the coronavirus. It is not a substitute for the COVID-19 vaccine, UK authorities said.

04/11/2021

World News

EU watchdog mulling authorisation of Merck's anti-COVID pill

The European Medicines Agency has started reviewing Merck's COVID-19 antiviral treatment, the first pill that has been shown to treat the disease.

25/10/2021

Health news

Could COVID pills be a game-changer for vaccine equity?

A new antiviral pill that has been shown to treat COVID-19 in high-risk patients is seeking authorisation.

20/10/2021

USA

Pfizer and Merck team up to work on anti-cancer treatment

17/11/2014